Zurich Cantonal Bank
DYN icon

Zurich Cantonal Bank’s Dyne Therapeutics DYN Stock Holding History

Zurich Cantonal Bank’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,307
Closed -$730K – 2861
2025
Q4 		$730K Buy
+37,307
New +$706K ﹤0.01% 1543

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Zurich Cantonal Bank's DYN Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Dyne Therapeutics (DYN) in Q1 2026: 52,152 shares worth $946K. The stake represents ﹤0.01% of the portfolio and ranks #1465 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in DYN as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in DYN in Q2 2023 and has held it in 11 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Zurich Cantonal Bank held 52,152 shares of Dyne Therapeutics worth $946K as of Q1 2026.
  • Dyne Therapeutics was a new Zurich Cantonal Bank position in Q1 2026.
  • Dyne Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1465 holding.
  • Zurich Cantonal Bank first reported a position in Dyne Therapeutics in Q2 2023 and has held it in 11 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.